Budget Impact Analysis (BIA) of Avelumab for the treatment of patients with urothelial cancer in Argentina

June 2025 - October 2025

  • Health Technology Assessment and Economic Evaluations
  • Concluded

Period: June 2025 – October 2025

Researchers: Natalia Espinola

Objectives:

  • Adapt the Budget Impact Analysis (BIA) model of Avelumab for the treatment of patients with urothelial cancer provided by the laboratory for the local case of the three health sectors in Argentina (PAMI sector, social security and private sector).
  • Adapt a Cost of Care model provided by the laboratory.
  • Develop an interactive visualization tool with the results of the Budget Impact Analysis model.

Type of study: Health Economics, AIP

Financier: MERCK